Ideaya Historical Income Statement
| IDYA Stock | USD 26.79 0.19 0.71% |
Historical analysis of Ideaya Biosciences income statement accounts such as Discontinued Operations of 0.0 or Depreciation And Amortization of 4.2 M can show how well Ideaya Biosciences performed in making a profits. Evaluating Ideaya Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Ideaya Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Ideaya Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ideaya Biosciences is a good buy for the upcoming year.
Ideaya |
About Ideaya Income Statement Analysis
Ideaya Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Ideaya Biosciences shareholders. The income statement also shows Ideaya investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Ideaya Biosciences Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Ideaya Biosciences. It is also known as Ideaya Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Ideaya Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Ideaya Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.At present, Ideaya Biosciences' Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 22.5 M, whereas Selling General Administrative is forecasted to decline to about 16.4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 506K | 3.8M | 21.5M | 22.5M | Net Interest Income | 506K | 3.8M | 21.5M | 22.5M |
Ideaya Biosciences income statement Correlations
Click cells to compare fundamentals
Ideaya Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ideaya Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | 2.3M | 849K | 506K | 3.8M | 21.5M | 22.5M | |
| Interest Income | 2.3M | 849K | 506K | 3.8M | 21.5M | 22.5M | |
| Depreciation And Amortization | 1.2M | 1.4M | 1.7M | 2.1M | 4.0M | 4.2M | |
| Selling General Administrative | 10.0M | 15.2M | 20.1M | 23.9M | 28.3M | 16.4M | |
| Gross Profit | (1.2M) | 19.5M | 27.9M | 50.9M | (106.1M) | (100.8M) | |
| Other Operating Expenses | 44.3M | 54.9M | 78.2M | 113.4M | 157.8M | 165.7M | |
| Operating Income | (44.3M) | (35.3M) | (50.3M) | (62.5M) | (134.4M) | (127.7M) | |
| Net Income From Continuing Ops | (42.0M) | (34.5M) | (49.8M) | (58.7M) | (113.0M) | (107.3M) | |
| Ebit | (44.3M) | (35.3M) | (50.3M) | (62.5M) | (134.4M) | (127.7M) | |
| Research Development | 34.3M | 39.7M | 58.2M | 89.5M | 129.5M | 136.0M | |
| Ebitda | (43.0M) | (34.0M) | (48.5M) | (60.4M) | (130.4M) | (123.9M) | |
| Cost Of Revenue | 1.2M | 39.7M | 1.7M | 2.1M | 129.5M | 136.0M | |
| Total Operating Expenses | 44.3M | 54.9M | 78.2M | 113.4M | 157.8M | 165.7M | |
| Reconciled Depreciation | 1.2M | 1.4M | 1.7M | 2.1M | 4.0M | 4.2M | |
| Income Before Tax | (42.0M) | (34.5M) | (49.8M) | (58.7M) | (113.0M) | (107.3M) | |
| Total Other Income Expense Net | 2.3M | 849K | 506K | 3.8M | 21.5M | 22.5M | |
| Net Income Applicable To Common Shares | (42.0M) | (34.5M) | (49.8M) | (58.7M) | (52.8M) | (55.4M) | |
| Net Income | (38.4M) | (32.3M) | (47.5M) | (54.8M) | (113.0M) | (107.3M) | |
| Income Tax Expense | (3.5M) | (2.2M) | (2.2M) | (3.8M) | 3.8M | 4.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ideaya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ideaya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ideaya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ideaya Biosciences Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 0.051 | Quarterly Revenue Growth (0.03) | Return On Assets (0.16) | Return On Equity (0.21) |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.